Clinical considerations in early-onset cerebral amyloid angiopathy

G Banerjee, J Collinge, NC Fox, T Lashley, S Mead… - Brain, 2023 - academic.oup.com
Cerebral amyloid angiopathy (CAA) is an important cerebral small vessel disease
associated with brain haemorrhage and cognitive change. The commonest form, sporadic …

Recent progress and research trend of anti-cataract pharmacology therapy: a bibliometric analysis and literature review

A Lu, P Duan, J Xie, H Gao, M Chen, Y Gong… - European Journal of …, 2022 - Elsevier
Cataract is the leading cause of blindness worldwide. Cataract phacoemulsification
combined with intraocular lens implantation causes great burden to global healthcare …

[HTML][HTML] Oxidative Stress and Cataract Formation: Evaluating the Efficacy of Antioxidant Therapies

M Kulbay, KY Wu, GK Nirwal, P Bélanger, SD Tran - Biomolecules, 2024 - mdpi.com
This comprehensive review investigates the pivotal role of reactive oxygen species (ROS) in
cataract formation and evaluates the potential of antioxidant therapies in mitigating this …

[HTML][HTML] Advances in amyloid-β clearance in the brain and periphery: implications for neurodegenerative diseases

R Ullah, EJ Lee - Experimental Neurobiology, 2023 - ncbi.nlm.nih.gov
This review examines the role of impaired amyloid-β clearance in the accumulation of
amyloid-β in the brain and the periphery, which is closely associated with Alzheimer's …

Emerging therapeutic opportunities of novel thiol-amides, NAC-amide (AD4/NACA) and thioredoxin mimetics (TXM-Peptides) for neurodegenerative-related disorders

D Atlas - Free Radical Biology and Medicine, 2021 - Elsevier
Understanding neurodegenerative diseases have challenged scientists for decades. It has
become apparent that a decrease in life span is often correlated with the development of …

Association of serum cystatin c with cerebral small vessel disease in community-based population

D Yao, S Li, J Jing, X Cai, A Jin, Y Yang, S Wang… - Stroke, 2022 - Am Heart Assoc
Background: The aim of this study was to investigate the relationship between serum
cystatin C levels and the presence and severity of cerebral small vessel disease (CSVD) …

The historical background of hereditary cystatin C amyloid angiopathy: Genealogical, pathological, and clinical manifestations

AO Snorradottir, H Hakonarson, A Palsdottir - Brain Pathology, 2024 - Wiley Online Library
Hereditary cystatin C amyloid angiopathy (HCCAA) is an Icelandic disease that belongs to a
disease class called cerebral amyloid angiopathy, a group of heterogenous diseases …

[图书][B] Genetic Causes of Amyloid Fibrils and Their Structures

GM Rosenberg - 2023 - search.proquest.com
The conversion of human proteins into the highly ordered fibrillar aggregates known as
amyloid fibrils is implicated in a wide range of diseases. The number of proteins known to …

Áhrif N-acetyl cysteine á meingerð arfgengrar heilablæðingar (HCCAA)

A Sigurðardóttir - 2022 - skemman.is
Arfgeng heilablæðing (Hereditary Cystatin C Amyloid Angiopathy, HCCAA) er séríslenskur
ríkjandi sjúkdómur sem erfist óháð kyni. Stökkbreyting á sér í CST3 geninu sem veldur því …

NACA impact on APP aggregation: the ability of NACA to interfere with aggregation of Amyloid precursor protein (APP) molecules

F Gunnarsdóttir - skemman.is
This research builds on the results of previous phase IIa clinical trials conducted by Arctic
Therapeutics. The outcome from that trial was favorable and suggests that N-Acetyl Cysteine …